139 related articles for article (PubMed ID: 18695744)
21. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction.
Tavassoli A; Lu Q; Gam J; Pan H; Benkovic SJ; Cohen SN
ACS Chem Biol; 2008 Dec; 3(12):757-64. PubMed ID: 19053244
[TBL] [Abstract][Full Text] [Related]
22. Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II.
Luo Z; Fan X; Zhou N; Hiraoka M; Luo J; Kaji H; Huang Z
Biochemistry; 2000 Nov; 39(44):13545-50. PubMed ID: 11063591
[TBL] [Abstract][Full Text] [Related]
23. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
[TBL] [Abstract][Full Text] [Related]
24. Molecular recognition in the human immunodeficiency virus capsid and antiviral design.
Bocanegra R; Rodríguez-Huete A; Fuertes MÁ; Del Álamo M; Mateu MG
Virus Res; 2012 Nov; 169(2):388-410. PubMed ID: 22728445
[TBL] [Abstract][Full Text] [Related]
25. Reactivity of sera from systemic lupus erythematosus and Sjögren's syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen.
Deas JE; Liu LG; Thompson JJ; Sander DM; Soble SS; Garry RF; Gallaher WR
Clin Diagn Lab Immunol; 1998 Mar; 5(2):181-5. PubMed ID: 9521140
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
Dorrell L; Willcox BE; Jones EY; Gillespie G; Njai H; Sabally S; Jaye A; DeGleria K; Rostron T; Lepin E; McMichael A; Whittle H; Rowland-Jones S
Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619
[TBL] [Abstract][Full Text] [Related]
27. Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes.
Herce HD; Garcia AE
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20805-10. PubMed ID: 18093956
[TBL] [Abstract][Full Text] [Related]
28. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
Druillennec S; Dong CZ; Escaich S; Gresh N; Bousseau A; Roques BP; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4886-91. PubMed ID: 10220388
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in silico binding study of the peptide derived from HIV-1 CA-CTD and LysRS as a potential HIV-1 blocking site.
Na Nakorn P; Treesuwan W; Choowongkomon K; Hannongbua S; Boonyalai N
J Theor Biol; 2011 Feb; 270(1):88-97. PubMed ID: 21093454
[TBL] [Abstract][Full Text] [Related]
30. Solution structure of LC5, the CCR5- derived peptide for HIV-1 inhibition.
Miyamoto K; Togiya K; Kitahara R; Akasaka K; Kuroda Y
J Pept Sci; 2010 Apr; 16(4):165-70. PubMed ID: 20196122
[TBL] [Abstract][Full Text] [Related]
31. Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.
Jang S; Hyun S; Kim S; Lee S; Lee IS; Baba M; Lee Y; Yu J
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10086-9. PubMed ID: 25056130
[TBL] [Abstract][Full Text] [Related]
32. MicroED structures of HIV-1 Gag CTD-SP1 reveal binding interactions with the maturation inhibitor bevirimat.
Purdy MD; Shi D; Chrustowicz J; Hattne J; Gonen T; Yeager M
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13258-13263. PubMed ID: 30530702
[TBL] [Abstract][Full Text] [Related]
33. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
[TBL] [Abstract][Full Text] [Related]
34. The role of nucleocapsid of HIV-1 in virus assembly.
Dawson L; Yu XF
Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
[TBL] [Abstract][Full Text] [Related]
35. Superior HIV-1 TAR Binders with Conformationally Constrained R52 Arginine Mimics in the Tat(48-57) Peptide.
Bhosle GS; Kharche S; Kumar S; Sengupta D; Maiti S; Fernandes M
ChemMedChem; 2018 Feb; 13(3):220-226. PubMed ID: 29314706
[TBL] [Abstract][Full Text] [Related]
36. SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide.
Naito T; Izumi K; Kodama E; Sakagami Y; Kajiwara K; Nishikawa H; Watanabe K; Sarafianos SG; Oishi S; Fujii N; Matsuoka M
Antimicrob Agents Chemother; 2009 Mar; 53(3):1013-8. PubMed ID: 19114674
[TBL] [Abstract][Full Text] [Related]
37. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
Lawless MK; Barney S; Guthrie KI; Bucy TB; Petteway SR; Merutka G
Biochemistry; 1996 Oct; 35(42):13697-708. PubMed ID: 8885850
[TBL] [Abstract][Full Text] [Related]
39. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.
Buseyne F; McChesney M; Porrot F; Kovarik S; Guy B; Rivière Y
J Virol; 1993 Feb; 67(2):694-702. PubMed ID: 7678303
[TBL] [Abstract][Full Text] [Related]
40. Maturation inhibitors facilitate virus assembly and release of HIV-1 capsid P224 mutant.
Timilsina U; Ghimire D; Adhikari LP; Bhattarai A; Mishra N; Rai M; Dubey RC; Gaur R
Virology; 2018 Aug; 521():44-50. PubMed ID: 29879541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
